Here is an extract of a further unanswered question from your June Q&A. This extract has had minor edits due to the passage of time.
I direct supplementary questions in regards to your ECT website, where I quote:
“Our core competencies in process development, applied research, business development and corporate governance underpin our strategic-partnering business model, which leverages industry expertise to drive technology development and mitigate risk while maintaining the agility necessary to navigate often-uncertain political, social and economic conditions”.
Home page Header Banner “India Australia Business and Community Awards Finalist 2018”
Questions.
1. What industry and in particular personnel expertise did you draw on to navigate often uncertain political, social and economic conditions that resulted in the outcome announced yesterday?
2. If question 1 formed part of an individual performance review balanced scorecard rating, what score would you give the individual personnel?
3. What risk mitigation strategies did you employ to maintain agility to navigate often uncertain political, social and economic conditions?
4. Who designed and was accountable for the risk mitigation strategy?
5. What is the purpose of maintaining the IABACA finalist banner on the website from 2018? All shareholders know ECT was a finalist however the winner of the award bagged it for a plug and play app for their mobile devices.
Thank you.
- Forums
- ASX - By Stock
- ECT
- ECT Q&A thread 23/7
ECT Q&A thread 23/7, page-9
-
-
- There are more pages in this discussion • 280 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.001(16.7%) |
Mkt cap ! $11.10M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $419 | 127.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
53 | 19761726 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 12532403 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
53 | 19761726 | 0.003 |
21 | 14265353 | 0.002 |
11 | 17800024 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 12532403 | 23 |
0.005 | 4374813 | 26 |
0.006 | 5239567 | 10 |
0.007 | 1118334 | 6 |
0.008 | 332213 | 4 |
Last trade - 15.43pm 15/07/2024 (20 minute delay) ? |
Featured News
ECT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online